Literature DB >> 7631331

Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma.

H S Markus1, J Barley, R Lunt, J M Bland, S Jeffery, N D Carter, M M Brown.   

Abstract

BACKGROUND AND
PURPOSE: A deletion (D)/insertion (I) polymorphism in the angiotensin-converting enzyme gene has been associated with myocardial infarction. Its relations to both stroke and atheroma remain uncertain. We examined its role as a risk factor in patients with cerebrovascular disease and its relation to carotid atheroma.
METHODS: One hundred one patients with symptomatic carotid artery territory cerebral ischemia were compared with 137 age-matched control subjects. In the patient group, carotid atheroma was assessed by measurement of degree of carotid stenosis and intima-media thickness with high-resolution duplex ultrasound. The D/I polymorphism was examined using the polymerase chain reaction.
RESULTS: D:I allele frequency was 0.59:0.41 in case subjects and 0.48:0.52 in control subjects (P = .01). The DD genotype was more common in patients with cerebrovascular disease compared with control subjects (36/101 versus 30/137, P = .02). The DD genotype conferred a relative risk of any type of cerebrovascular disease of 1.98 (95% confidence interval [CI], 1.11 to 3.51; P = .02). However, this was largely due to a strong association in the 18 patients with lacunar stroke, in whom the D:I ratio was 0.75:0.25 (P = .0097 versus control subjects). The odds ratio for lacunar stroke associated with the DD genotype was 5.6 (95% CI, 2.0 to 15.7) and was still significant at 4.40 (95% CI, 1.45 to 12.6; P < .009) after controlling for other risk factors. There was no significant association between angiotensin-converting enzyme genotype and cerebrovascular disease due to large-vessel stenosis. There was no association between genotype and age, sex, smoking history, diabetes, or cholesterol level.
CONCLUSIONS: The deletion polymorphism in the angiotensin-converting enzyme gene is a new independent risk factor for lacunar stroke but is not a risk factor for stroke associated with carotid stenosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7631331     DOI: 10.1161/01.str.26.8.1329

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  23 in total

1.  Meta-analysis of the ACE gene in ischaemic stroke.

Authors:  P Sharma
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-02       Impact factor: 10.154

2.  Endothelial Nitric Oxide Synthase and Angiotensin Converting Enzyme Gene Polymorphisms in Migraine Patients.

Authors:  Tammam Sipahi; Babürhan Güldiken; Levent Kabayel; Orkide Palabiyik; Hülya Özkan; Tülay Okman Kiliç; Necdet Süt; Nilda Turgut
Journal:  Noro Psikiyatr Ars       Date:  2013-09-01       Impact factor: 1.339

Review 3.  What can knockout mice contribute to an understanding of hypertension?

Authors:  L P Audoly; T H Le; T M Coffman
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

4.  C677T methylentetrahydrofulate reductase and angiotensin converting enzyme gene polymorphisms in patients with Alzheimer's disease in Iranian population.

Authors:  Mohammad Reza Keikhaee; Susan Bany Hashemi; Hossein Najmabadi; Maryam Noroozian
Journal:  Neurochem Res       Date:  2006-08-12       Impact factor: 3.996

5.  Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromes.

Authors:  A Hassan; A Lansbury; A J Catto; A Guthrie; J Spencer; C Craven; P J Grant; J M Bamford
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

6.  Pathophysiology of vascular dementia.

Authors:  Francesco Iemolo; Giovanni Duro; Claudia Rizzo; Laura Castiglia; Vladimir Hachinski; Calogero Caruso
Journal:  Immun Ageing       Date:  2009-11-06       Impact factor: 6.400

Review 7.  Risk of "silent stroke" in patients older than 60 years: risk assessment and clinical perspectives.

Authors:  Jae-Sung Lim; Hyung-Min Kwon
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

8.  Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke.

Authors:  Z Szolnoki; F Somogyvári; A Kondacs; M Szabó; L Fodor; J Bene; B Melegh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

Review 9.  Cerebral small vessel disease: genetic risk assessment for prevention and treatment.

Authors:  Ada Lam; M Anne Hamilton-Bruce; Jim Jannes; Simon A Koblar
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

10.  Apolipoprotein E, angiotensin-converting enzyme and kallikrein gene polymorphisms and the risk of Alzheimer's disease and vascular dementia.

Authors:  H K Wang; H C Fung; W C Hsu; Y R Wu; J C Lin; L S Ro; K H Chang; F J Hwu; Y Hsu; S Y Huang; G J Lee-Chen; C M Chen
Journal:  J Neural Transm (Vienna)       Date:  2006-02-09       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.